SY Holdings (06069) announced its performance in 2025, achieving a net profit of approximately 483 million yuan, a year-on-year increase of 23.6%. The final dividend is 40.47 cents per share.
Shengye (06069) announced its performance in 2025, with main business revenue and income of approximately 903.5 million yuan, a year-on-year decrease of 1.7%; net profit of approximately 483 million yuan, a year-on-year increase of 23.6%; earnings per share of 48 cents, with a proposed final dividend of 40.47 cents per share.
SY Holdings (06069) announced its performance in 2025, with main business revenue and earnings at approximately 903.5 million yuan, a decrease of 1.7% year-on-year; net profit of approximately 483 million yuan, an increase of 23.6% year-on-year; earnings per share of 48 cents, with a proposed final dividend of 40.47 cents per share.
The announcement stated that the decrease in main business revenue and earnings was mainly due to the group's continued deepening of its light asset strategy, strengthening of its technology platform capabilities, and guiding the supply chain funding turnover needs of more small and medium-sized enterprises through external funding partners linked to the platform. As a result, revenue from digital financial solutions continued to decrease, but this impact has been partially offset by the significant growth in platform technology service revenue driven by the platformization strategy.
As of December 31, 2025, the total number of platform customers has exceeded 23,000, an increase of approximately 27.0% compared to the 18,100 as of December 31, 2024; in the fiscal year ending December 31, 2025, the proportion of small and medium-sized customers exceeded 96%; the total business scale intelligently matched on the platform exceeded 332.4 billion yuan, an increase of approximately 33.6% compared to the 248.9 billion yuan as of December 31, 2024; the group has accumulated more than 3.3 billion yuan in cost savings for small and medium-sized enterprise customers.
Related Articles

US Stock Market Move | "Wuma Technology (ISPR.US) surged over 26%, FDA draft expected to create huge value for shareholders"

US Stock Market Move | Eli Lilly (LLY.US) fell by over 4%, Sophirion Biotech (GPCR.US) released positive data on its experimental weight-loss drug.
.png)
US Stock Market Move | RLX Technology, Inc. Sponsored ADR Class A (RLX.US) rose more than 4%, with a year-on-year increase in net revenue of 44% in 2025.
US Stock Market Move | "Wuma Technology (ISPR.US) surged over 26%, FDA draft expected to create huge value for shareholders"

US Stock Market Move | Eli Lilly (LLY.US) fell by over 4%, Sophirion Biotech (GPCR.US) released positive data on its experimental weight-loss drug.

US Stock Market Move | RLX Technology, Inc. Sponsored ADR Class A (RLX.US) rose more than 4%, with a year-on-year increase in net revenue of 44% in 2025.
.png)
RECOMMEND

European Carmakers Embrace China: Under Technology And Cost Pressure, Stellantis And Mercedes Seek Partnerships With Chinese Automakers
17/03/2026

HKEX Listing Mechanism Reform Revisited: How To Balance New Favorites And Established Names
17/03/2026

International Oil Prices Plunge Boosts U.S. Stocks; Morgan Stanley Chief Says Market Correction Nearing End
17/03/2026


